-63.6%
CLSK vs THC
+1,506.4%
-1,570.0%
-98.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.9% | +0.6% | +0.3% | +0.7% |
| 7D | +8.8% | -0.7% | +9.5% | +9.0% |
| 30D | -6.0% | +1.3% | -7.3% | -6.4% |
| 3M | -24.4% | +64.2% | -88.6% | -35.1% |
| 6M | +19.0% | +8.3% | +10.8% | +14.4% |
| YTD | +25.4% | +33.4% | -8.0% | +12.6% |
| 1Y | +39.8% | +37.7% | +2.1% | +24.7% |
| 3Y | +177.7% | +236.8% | -59.1% | +87.0% |
| 5Y | -11.0% | +249.3% | -260.3% | -41.2% |
| All | -63.6% | +1,506.4% | -1,570.0% | -79.1% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling